| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 190,055 | |||
| Accounts receivable, net | 3,481 | |||
| Inventory | 5,729 | |||
| Prepaid expenses and other current assets | 8,806 | |||
| Total current assets | 208,071 | |||
| Property and equipment gross | 48,108 | |||
| Less accumulated depreciation and amortization | 5,534 | |||
| Property and equipment, net | 42,574 | |||
| Intangible assets, net | 120 | |||
| Operating lease right-to-use assets | 376 | |||
| Other non-current assets | 1,299 | |||
| Total assets | 252,440 | |||
| Accounts payable | 8,540 | |||
| Accrued expenses and other current liabilities | 12,332 | |||
| Lease liability, short term | 159 | |||
| Total current liabilities | 21,031 | |||
| Lease liability, long term | 266 | |||
| Total liabilities | 21,297 | |||
| Common stock, 0.001 par value 1,000,000,000 shares authorized 10,168,204 and 4,385,929 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 10 | |||
| Additional paid in capital | 1,039,212 | |||
| Accumulated deficit | -807,805 | |||
| Accumulated other comprehensive loss | -274 | |||
| Total stockholders equity | 231,143 | |||
| Total liabilities and stockholders equity | 252,440 | |||
Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. (TNXP)